Design of a folding inhibitor of the HIV-1 protease

被引：2

作者：

Tiana, G

Broglia, RA

Sutto, L

Provasi, D

机构：

[1] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy

[2] Ist Nazl Fis Nucl, I-20133 Milan, Italy

[3] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark

来源：

MOLECULAR SIMULATION | 2005年 / 31卷 / 11期

关键词：

HIV-1; protease; Monte Carlo simulations; local elementary structures; HIV-PR monomer;

D O I：

10.1080/089270500262721

中图分类号：

O64 [物理化学（理论化学）、化学物理学];

学科分类号：

070304 ; 081704 ;

摘要：

A novel way to inhibit HIV-1 protease by destabilizing its native state is discussed. A simplified protein model is used together with Monte Carlo simulations, to assess the destabilizing effect of peptides displaying the same sequence as specific fragments of the protein which are essential for its stability. Model calculations also show that it is unlikely that the protein can escape the inhibitory peptide by point mutations.

引用

页码：765 / 771

页数：7

共 50 条

[41] Interdependence of inhibitor recognition in HIV-1 protease subsites
Paulsen, Janet
Leidner, Florian
Ragland, Debra
Yilmaz, Nese Kurt
Schiffer, Celia
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[42] DESIGN OF HYBRID INHIBITORS TO HIV-1 PROTEASE
Zhang, Da W.
Huang, Philip Lin
Lee-Huang, Sylvia
Zhang, John Z. H.
JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY, 2008, 7 (04): : 485 - 503
[43] Computational design of mutation-resistant HIV-1 protease inhibitor libraries.
Chellappan, S
Gilson, MK
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U804 - U804
[44] IRREVERSIBLE HIV-1 PROTEASE INHIBITOR: STRUCTURE, DESIGN AND KINETICS OF CYCLIC UREA EPOXIDES
Chang, Chong-Hwan
De Lucca, Indawati
Klabe, Ronald
Duke, Jodie
Huston, Edward
Hodge, Nicolas
Aldrich, Paul
Nugiel, David
DeLucca, George
Meek, James
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 151 - 151
[45] A PRELIMINARY-STUDY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE, TO TREAT HIV-1 INFECTION
MARKOWITZ, M
SAAG, M
POWDERLY, WG
HURLEY, AM
HSU, A
VALDES, JM
HENRY, D
SATTLER, F
LAMARCA, A
LEONARD, JM
HO, DD
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23): : 1534 - 1539
[46] Investigating the folding mechanism of HIV-1 protease, a dimeric β-barrel protein
Fitzgerald, AA
Wu, Y
Kundu, A
Matthews, CR
PROTEIN SCIENCE, 2004, 13 : 107 - 107
[47] Targeting structural flexibility in HIV-1 protease inhibitor binding
Hornak, Victor
Simmerling, Carlos
DRUG DISCOVERY TODAY, 2007, 12 (3-4) : 132 - 138
[48] Prediction of HIV-1 Protease/Inhibitor Affinity using RosettaLigand
Lemmon, Gordon
Kaufmann, Kristian
Meiler, Jens
CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (06) : 888 - 896
[49] Amprenavir - A protease inhibitor for the treatment of patients with HIV-1 infection
Reddy, P
Ross, J
FORMULARY, 1999, 34 (07) : 567 - +
[50] Antimalarial activity of HIV-1 protease inhibitor in chromone series
Lerdsirisuk, Pradith
Maicheen, Chirattikan
Ungwitayatorn, Jiraporn
BIOORGANIC CHEMISTRY, 2014, 57 : 142 - 147

← 1 2 3 4 5 →